About the Workshop
Institute of Chemical Technology "Biosimilar Workshop" is one of the largest gatherings of Biopharmaceutical Researchers in India. In its 4th year, the Biosimilar workshop attracts professionals from biotech, biopharma, academia, and start-ups for two days of rigorous learning and networking opportunities to discover new prospects and good alliances. “Biopharmaceutical Product Development: Indulge, Innovate & Inspire” includes a wide range of topics, from cell line development, process development, biomanufacturing, regulatory science, clinical trials, and industry 4.0. This event will provide an opportunity to meet experts, professionals, academicians, and researchers from all over the world further opening doors to new practices or revising existing practices based on the work presented in workshops, poster presentations, and inspired thought processes by the leadership of the industry.
Salient Features
Sponsors
Collaborators
Media Partners
Session Keynote Speakers
Gennova Biopharmaceuticals Ltd
Biological E. Limited
Sun Pharma Advanced Research Company Ltd
cell and gene therapy lab Children's Hospital of Philadelphia
IIT-Bombay
Session Speakers and Moderators
Co-founder and CEO SymphonyTech Biologics
Topic : mRNA Vaccine Development: Challenges and Opportunities
Organisation : SymphonyTech Biologics
Topic : CGT Product Development: Challenges and Opportunities.
Organization : IIT-Bombay
Topic : CGT Product Development: Challenges and Opportunities.
Organization : Intas Pharmaceuticals
Topic : Novel: The future of Biologics
Organization : Zumutor Biologics
Topic : Cell Line and Upstream Process Development
Organization : Ipca Laboratories Ltd
Topic : Protein Aggregation and Biophysical Characterization
Organization : Biocon Biologics Limited
Topic : Process Analytical Technologies and Data Analytics
Organization : IIT Delhi
Topic : Advances in Purification Technologies
Organization : National Chemical Laboratory
Topic : Mass Spectroscopy for Protein and Peptide Characterization
Organization : U.S. Pharmacopeia
Topic : Industry 4.0
Organization : TÜV SÜD
Topic : Advances in single-use technology
Organization : Intas Pharmaceuticals
Topic : Formulation Technologies and Excipient-Protein Interaction
Organization : KBI Biopharma, Geneva
Topic : FDA Compliance: Meeting regulatory expectations in product development and manufacturing
Organization : Biopharmaceutical Industry Professional
Topic : FDA Compilance: Meeting regulatory expectations in product development and manufacturing
Organization : US-FDA, India
Topic : Challenges and Opportunities in MSAT
Organization : Bharat Serums and Vaccines Ltd
Topic : Challenges to Conduct Clinical Trials for Newer Therapies
Organization : TATA MEMORIAL HOSPITAL
Topic : Cell-based Potency assays – design and considerations
Organization : U.S. Pharmacopeia
Topic : Development of Complex Peptide Generics: Analytical and Regulatory Challenges
Organization : Sun Pharma
Topic : Role of Government and Funding Agencies towards Promotion of Biopharmaceutical Industry
Organization : Syngene International Limited
Topic : Novel: The future of Biologics
Organisation : Sun Pharma Advanced Research Company Ltd
Topic : mRNA Vaccine Development: Challenges and Opportunities
Organisation : Gennova Biopharmaceuticals Ltd
Topic : mRNA Vaccine Development: Challenges and Opportunities
Organization : Perelman School of Medicine, University of Pennsylvania
Topic : CGT Product Development: Challenges and Opportunities.
Organization : The University of Texas MD Anderson Cancer Center
Topic : Role of Government and Funding Agencies towards Promotion of Biopharmaceutical Industry
Organization : Department of Biotechnology, Government of India
Topic : Role of Government and Funding Agencies towards Promotion of Biopharmaceutical Industry
Organization : BIRAC, Department of Biotechnology Government of India
Topic : Role of Government and Funding Agencies towards Promotion of Biopharmaceutical Industry
Organization : Mynvax Pvt Ltd
Topic : Role of Government and Funding Agencies towards Promotion of Biopharmaceutical Industry
Organization : Syngene International Limited
Topic : Protein Aggregation and Biophysical Characterization
Organization : Hetero Biopharma Limited
Topic : Protein Aggregation and Biophysical Characterization
Organization : IIT-Bombay
Topic : Process Analytical technologies and Data Analytics
Organization :
Topic : FDA Compilance: Meeting regulatory expectations in product development and manufacturing
Organization : US-FDA, India
Topic : FDA Compilance: Meeting regulatory expectations in product development and manufacturing
Organization : Biocon Lmited
Topic : FDA Compilance: Meeting regulatory expectations in product development and manufacturing
Organization : Lupin Pharmaceuticals
Topic : FDA Compilance: Meeting regulatory expectations in product development and manufacturing
Organization : Q-Exl Partners
Topic : Novel: The future of Biologics
Organisation : Indian Institute of Science, Bangalore
Topic : Novel: The future of Biologics
Organisation : Cytiva
Topic : Novel: The future of Biologics
Organisation : Mazumdar Shaw Medical Foundation
Topic : Novel: The future of Biologics
Organisation : Biocon Biologics
Topic : Novel: The future of Biologics
Organisation : Premas Biotech
Topic : Challenges to Conduct Clinical Trials for Newer Therapies
Organization : Mynvax Pvt.ltd
Topic : Protein Aggregation and Biophysical Characterization
Organization : Agilent Technologies
Topic : Mass Spectroscopy for Protein and Peptide Characterization
Organization : USP
Topic : Novel: The future of Biologics
Organisation : Indian Institute of Science, Bangalore
Topic : mRNA Vaccine Development: Challenges and Opportunities
Organisation : Global Biologics, USP
Attended by over 600+ participants
Our Happy Industry Leaders
– Bill Gates
Here is what our industry leaders have to say about our past events!
Francis Crawley
“We have an excellent workshop, so think this is a good promise for the future of the Biopharmaceutical Industry here in India, and I was very happy to be able to join you, listen to you, and learn from you”
Dr. Saroj Maramvekar
It’s a very good platform for students and people from the industry to learn exactly about how the processes happen and how the processes are developed and how you can utilize them in your field. So, it's a very good experience for everybody.
Kavitha Iyer Rodrigues
I think there has been a significant mind shift on how people would go for affordable biologics. ICT has done an amazing job and I want to really thank Dr. Ratnesh and the group for getting together a key set of people in deliberating on certain things and also the movers and shakers which inspires the students and people in the industry.
Dr. Kevin Carrick
I would like to thank the organizers of the ICT- ”Hands-on Training Program in Pharmaceutical Product Development” for offering a wonderful program and having very engaged students who listened and who were very responsive to questions.
OUR BLOG
Recent Articles and News
Monoclonal antibodies (mAbs) form an important therapeutic agent for the treatment of several diseases.
READ MORE
It is estimated that new drugs take an average of 8–10 years to hit the shelves, costing around $ 1 billion
READ MORE
In today’s world, biotechnology has become one of the most important industries, as it deals with the important area of human healthcare.
READ MORE
With the advances in science and medicine, the fundamental approach towards diagnosis and treatment of various diseases has improved significantly over the years.
READ MORE